We are live on ! Find out more
LCM

Legato Capital Management Portfolio holdings

AUM $1.21B
1-Year Est. Return 82.36%
This Fund
S&P 500
This Quarter Est. Return
+16.16%
1 Year Est. Return
+82.36%
3 Year Est. Return
+243.02%
5 Year Est. Return
+342.37%
10 Year Est. Return
+764.01%
AUM
$918M
AUM Growth
+$78.7M
Cap. Flow
-$9.19M
Cap. Flow %
-1%
Top 10 Hldgs %
12.06%
Holding
631
New
69
Increased
135
Reduced
112
Closed
73

Top Buys

Rank Stock Value
1
VC icon
Visteon
VC
+$2.62M
2
SYM icon
Symbotic
SYM
+$2.58M
3
CLMB icon
Climb Global Solutions
CLMB
+$2.58M
4
ADBE icon
Adobe
ADBE
+$1.81M
5
ROAD icon
Construction Partners
ROAD
+$1.77M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.62M
2
VRNA
Verona Pharma
VRNA
+$3.24M
3
SHO icon
Sunstone Hotel Investors
SHO
+$2.69M
4
BAC icon
Bank of America
BAC
+$2.21M
5
AMGN icon
Amgen
AMGN
+$2.19M

Sector Composition

Rank Sector Weight
1 Technology 27.75%
2 Industrials 21.74%
3 Healthcare 15.84%
4 Consumer Discretionary 10.72%
5 Financials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNL icon
151
Broadstone Net Lease
BNL
$4.02B
$1.81M 0.2%
101,458
+18,636
+23% +$320K
TSEM icon
152
Tower Semiconductor
TSEM
$28.5B
$1.8M 0.2%
24,829
– –
FAST icon
153
Fastenal
FAST
$59.5B
$1.79M 0.19%
36,410
– –
ADBE icon
154
Adobe
ADBE
$105B
$1.78M 0.19%
+5,057
New +$1.81M
MA icon
155
Mastercard
MA
$493B
$1.77M 0.19%
3,108
– –
VRRM icon
156
Verra Mobility
VRRM
$744M
$1.77M 0.19%
71,512
+19,842
+38% +$491K
XERS icon
157
Xeris Biopharma Holdings
XERS
$1.45B
$1.76M 0.19%
216,805
– –
TMO icon
158
Thermo Fisher Scientific
TMO
$220B
$1.76M 0.19%
3,632
– –
J icon
159
Jacobs Solutions
J
$17B
$1.74M 0.19%
11,605
– –
LIN icon
160
Linde
LIN
$226B
$1.71M 0.19%
3,609
– –
TVTX icon
161
Travere Therapeutics
TVTX
$5.78B
$1.7M 0.18%
+71,030
New +$1.34M
SKYW icon
162
Skywest
SKYW
$4.34B
$1.68M 0.18%
16,649
– –
SYNA icon
163
Synaptics
SYNA
$4.15B
$1.65M 0.18%
24,097
+15,159
+170% +$1.03M
ARLO icon
164
Arlo Technologies
ARLO
$1.65B
$1.65M 0.18%
97,110
-328
-0.3% -$5.58K
GBCI icon
165
Glacier Bancorp
GBCI
$6.35B
$1.65M 0.18%
33,818
– –
EXPD icon
166
Expeditors International
EXPD
$23.2B
$1.63M 0.18%
13,257
– –
RVMD icon
167
Revolution Medicines
RVMD
$44B
$1.62M 0.18%
34,654
+19,637
+131% +$769K
AJG icon
168
Arthur J. Gallagher & Co
AJG
$63.6B
$1.61M 0.18%
5,210
– –
REYN icon
169
Reynolds Consumer Products
REYN
$5.59B
$1.61M 0.18%
+65,747
New +$1.49M
CSCO icon
170
Cisco
CSCO
$479B
$1.6M 0.17%
23,337
– –
VIAV icon
171
Viavi Solutions
VIAV
$9.66B
$1.59M 0.17%
125,636
+24,086
+24% +$265K
DHR icon
172
Danaher
DHR
$144B
$1.59M 0.17%
8,031
+1,343
+20% +$267K
PAY icon
173
Paymentus
PAY
$4.86B
$1.59M 0.17%
51,867
+24,385
+89% +$806K
CHKP icon
174
Check Point Software Technologies
CHKP
$13.1B
$1.59M 0.17%
7,666
– –
LOW icon
175
Lowe's Companies
LOW
$125B
$1.58M 0.17%
6,282
– –
5 6
7
8 9

Similar funds

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return

Legato Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Legato Capital Management held 631 positions worth $918M, up 9.4% from $839M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Legato Capital Management's Q3 2025 filing shows 69 new, 135 increased, 112 reduced and 73 closed positions. Its largest new stake was Visteon: 22,225 shares worth $2.66M. The largest sale was Broadcom, an estimated $3.62M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Legato Capital Management's largest Q3 2025 buy was Visteon: 22,225 shares worth $2.66M.
  • Legato Capital Management added most to Construction Partners in Q3 2025, an estimated $1.77M increase.
  • Legato Capital Management's biggest Q3 2025 reduction was Broadcom, cutting an estimated $3.62M.
  • Legato Capital Management fully exited Verona Pharma in Q3 2025, selling an estimated $3.24M.
  • Legato Capital Management's ten largest holdings make up 12% of its $918M portfolio in Q3 2025.
  • Legato Capital Management opened 69 new positions and closed 73 in Q3 2025.
  • Legato Capital Management's portfolio value rose 9.4% quarter-over-quarter to $918M.

Based on Legato Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.